Patents/Assignees

Theraclone Sciences Inc.

3 patents in portfolio

US12410243utility2025
Methods of Treating HIV-1 Infection Utilizing Broadly Neutralizing Human Immunodeficiency Virus Type 1 (HIV-1) Gp120-specific Monoclonal Antibodies
0 cites
US12018067utility2024
Monoclonal Antibodies Directed Against Trimeric Forms of the HIV-1 Envelope Glycoprotein with Broad and Potent Neutralizing Activity
0 cites
US11584789utility2023
Monoclonal Antibodies Directed Against Trimeric Forms of the HIV-1 Envelope Glycoprotein with Broad and Potent Neutralizing Activity
0 cites